Journal: Advanced Science
Article Title: Activation of ERBB4 Pathway Inhibits Pathological Transdifferentiation of Lung Epithelial Progenitors into CD66c + Basal Cells in Severe Lung Injury
doi: 10.1002/advs.202519151
Figure Lengend Snippet: Loss of ERBB4 expression in epithelial cells of IPF lungs. (a) Multiplex immunofluorescence (IF) staining of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) showing nuclei (DAPI, blue), CD66c (green), KRT5 (magenta), and αSMA (gray). The white dashed box marks the region shown in panel (b). Scale bars, 50 µm. (b) Higher‐magnification views of the boxed region in panel (a) show CD66c + KRT5 + basal cells (BCs; arrows) adjacent to αSMA + myofibroblasts in IPF lungs (lower row). Representative healthy lung tissue is shown in the upper row for comparison. Scale bars, 50 µm. (c) Spatial proximity of epithelial subsets to αSMA + regions in IPF lungs. Violin plots show the distribution of nearest‐neighbor distances from epithelial cells to αSMA + myofibroblasts for CD66c + BCs, CD66c − BCs, and CD66c + secretory cells (SCs; CD66c + KRT5 − ). White squares and thick lines denote medians and interquartile ranges, respectively. Median distances (µm) are shown above. Data were obtained from multiplex IF images of two IPF patients ( n = 2). (d) Multiplex IF of normal alveoli shows strong ERBB4 (magenta) colocalized with the AT2 marker SFTPC (white), with minimal or no KRT5 + BCs (green). Nuclei: DAPI (blue). Scale bars, 50 µm. (e) In normal airways, ERBB4 (magenta) is expressed in CC10 + SCs (green) but is minimal or absent in KRT5 + BCs (white). Nuclei: DAPI (blue). Scale bars, 50 µm. (f) Low‐magnification view of IPF parenchyma reveals honeycomb cysts labeled for DAPI (blue), KRT5 (green), ERBB4 (magenta), and SFTPC (gray). Scale bars, 50 µm. (g) Enlarged view of the boxed region in panel (f) highlights honeycomb cysts densely lined with KRT5 + BCs and reduced ERBB4 expression, with few SFTPC + AT2 cells. Scale bars, 50 µm. (h) Residual alveolar regions in IPF lungs exhibit reduced ERBB4 expression in SFTPC + AT2 cells. Scale bars, 50 µm. (i) UMAP plots of scRNA‐seq data comparing normal distal lung epithelium (left, this study) and IPF lung tissue (right, Kathiriya et al., 2022). ERBB4 expression is enriched in normal epithelium, particularly in AT2 and SC clusters (outlined), but is markedly reduced in IPF lungs. (j) Proposed model of ERBB4 signaling in regulating epithelial plasticity during lung injury. Distal lung epithelial progenitors (AT2 cells, secretory cells, and CD66c − BCs) exhibit lineage plasticity and can converge toward a CD66c + basal state under injury‐associated conditions. During physiological repair, NRG1‐ERBB4‐MAPK signaling maintains epithelial identity and restrains aberrant basalization, in association with balanced BMP‐ and TGFβ‐related programs. In IPF, attenuation of ERBB4 signaling coincides with increased generation of pro‐fibrotic CD66c + BCs within disease‐associated niches enriched for TGFβ‐ and YAP‐related activity, contributing to pathological remodeling and impaired regeneration.
Article Snippet: Primary antibodies included: HT2‐280 (1:200, Terrace Biotechnologies, TB‐27AHT2‐280), KRT5 (1:500, ABclonal, 9661), CD66c (1:50, BioLegend, 365002), HBEGF (1:200, Bioss, bs‐3576R), MUC1 (1:200, BD Pharmingen, 555925), αSMA (1:500, Sigma, C6198), Ki67 (1:500, BD Biosciences, 550609), HER2 (1:200, Abcam, ab134182), SCGB1A1 (1:500, R&D Systems, MAB4218‐SP), PDPN (1:200, BioLegend, 337001), SFTPB (1:200, Santa Cruz, sc‐133143), SFTPC (1:200, Millipore, AB3786; alternatively, Abcam, ab312850), ERBB4 (1:50, Invitrogen, MA1‐861), and CDH1 (1:400, BD Biosciences, 610181).
Techniques: Expressing, Multiplex Assay, Immunofluorescence, Staining, Comparison, Marker, Labeling, Activity Assay